Our Corporate M&A team counseled an Italian subsidiary of a U.S. biotech multinational company in the preparation for entrance into the share capital of some Italian investors together with our U.S. colleagues.

Our team  also negotiated a complex shareholders’ agreement signed between the controlling shareholder and the new members.